Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Azd-9291 can be used to develop pharmaceuticals for non-small cell advanced lung growth and oral pharmaceuticals for patients with advanced non-small cell lung growth. At the same time, the therapy effect of advanced lung growth patients taking domestic camena, gefitinib (iressa) erlotinib hydrochloride (tarceva) after pharmaceutical resistance is very obvious.
item | value |
Packaging | Drum, Vacuum Packed |
Place of Origin | China;Shaanxi |
Grade | Food and Pharmaceutical Grade |
MOQ | 10g |
CAS | 1369773-39-6 |
Sample | Avaliable |
Shelf Life | 2 Years |
The T790M mutation will occur in most patients who are resistant to gefitinib (iressa), domestic camena, and erlotinib hydrochloride (tarceva), and there is no alternative pharmaceutical for these patients.
The launch of AZD9291 offers hope for these patients.
AZD9291 | Lapatinib ditosylate | Lapatinib | Gefitinib |
Niraparib | Imatinib mesylate | Imatinib | LOXO 101 |
Ibrutinib | Cabozantinib Malate | baricitinib | Erlotinib Hydrochloride |
a. Customs clearance
1) By Express:
Normally there is no specical need for the recipient to clear the customs. If the customs has an objection,our rich experienced and peofessional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
b. Payment
T/T,Wester Union,MoneyGram,****** Trade Assurance,L/C ,Bank transfer etc.